Participated · Series B · Sep 2021

Stellapps began by building a Digital Access Network (DAN) offering end-to-end digitised supply-chain solutions and has expanded into value-added dairy products under the mooMark brand. The company leverages IoT, advanced analytics and artificial intelligence, and partnerships with financial, insurance, veterinary, and cattle-nutrition providers to create value for small farmers and stakeholders. mooMark uses a tech-powered, low-capex approach for contract manufacturing and private labeling of traceable value-added dairy products, emphasising product traceability and reduced carbon footprints at the farm level. Stellapps' solutions are deployed in over 42,000 villages and digitise the flow of more than 14 million liters of milk every day. Financially, the company has raised over USD 50 million to date, including a recent USD 26 million Series C (equity and debt) and a USD 18 million pre-Series C from Nutreco in October 2021. The company intends to use the new capital to scale mooMark across India, strengthen its export segment, and support FMCG, D2C, and HoReCa customers focused on sustainability and traceability. Stellapps offers Internet-of-Things and digital solutions for the dairy supply chain, including smartMoo technology to enhance productivity, milk quality, and traceability. Its platform enables ecosystem partnerships to give farmers access to financial services, quality nutrition, and veterinary care, while its mooPay arm delivers digital payments, banking, savings, credit, and insurance. The company says it empowers farmers through technology, farm inputs, and market linkages and works with dairy farms, cooperatives, and private dairies across India, Nepal, Kenya, Bulgaria, Russia, and France. Stellapps plans to use the new funding to scale its traceability network and extend its digital footprint. The firm was incubated at the Rural Technology Business Incubator at IIT Madras and has previously received seed funding from Omnivore Partners. Stellapps is an IIT‑Madras incubated dairytech company that provides end-to-end farm optimization and monitoring solutions to dairy farmers and cooperatives. The startup leverages IoT, cloud, mobility, big data and analytics to improve milk production, procurement, cold chain, animal insurance and farmer payments. Its products and mechanization tools aim to maximize farmer profits while minimizing effort across the agri-dairy supply chain. Stellapps was founded by Ranjith Mukundan and Venkatesh Seshasayee and is based in Bengaluru. The company has previously raised a Series A from Blume Ventures and counts Flipkart executive chairman Binny Bansal among its supporters. It is currently raising follow-on capital as part of its Series B activity, indicating an active growth/expansion phase. Stellapps develops a full-stack IoT platform that spans precision farming, milk procurement, cold chain logistics and processing for the dairy sector. Its product suite includes SmartFarms, smartAMCU, ConTrak, AgRupay and MooKare. The company serves dairy clients across India, Nepal, Kenya, Bulgaria, Russia and France. Founded in April 2011 and incubated at the rural technology business incubator in IIT Madras, Stellapps combines hardware (wearables) and software to monitor milk quantity and quality and cattle health. The startup plans to use new capital for product development and geographic and commercial expansion, including wearable devices and cold‑chain infrastructure to help reduce costs for dairy value‑chain participants. Stellapps provides an end-to-end IoT data collection and analytics stack for the dairy supply chain, covering farm wearables, procurement sensors, cold-chain monitoring, payments, and insurance products. Its product suite includes SmartFarms, smartAMCU, ConTrak, AgRupay, and MooKare, and the full stack employs 26 different sensors across the chain. Wearable devices capture animal-specific data, quality sensors measure milk fat at collection sites, and cold-chain sensors monitor storage conditions; records are sent to company headquarters and to farmers via SMS. Stellapps reports having captured over $1 million of transaction data and serves dairy farms, cooperatives, and private dairies. Upfront hardware and platform costs range from $500–$1,500 with cloud service fees of $8–$10 per month, and the company is working with local banks to finance upfront costs. The system is designed for smallholder farms, runs on 2G data speeds, and Stellapps is developing a proprietary antenna to address rural connectivity issues. The company is pursuing international expansion and white‑label partnerships, with use in parts of Nepal and Kenya and plans to white‑label with agricultural retailers in France.

Participated · Equity · Feb 2021

Excision BioTherapeutics develops CRISPR-based antiviral therapies designed to eliminate viral genomes from infected patients. Its lead candidate, EBT-101, is being advanced into a Phase 1/2 clinical trial for people with chronic HIV infection. The company also supports preclinical programs including EBT-103 targeting JC virus (PML), EBT-104 for herpes simplex virus, and EBT-107 for hepatitis B. Excision says it has demonstrated a functional cure for HIV in animal models and is developing technologies and IP originating at Temple University and UC Berkeley. The company is located in San Francisco and plans to use recent financing to build team and infrastructure to progress its programs. Management states the work aims to deliver potentially curative therapies to patients with chronic viral infections. Excision BioTherapeutics develops advanced gene-editing therapeutics aimed at treating and eradicating life-threatening diseases caused by neurotropic viruses. Its core product is an HIV-1-targeted CRISPR platform designed to fully remove/excise the HIV-1 genome from all human cells and tissues. The company plans to use this platform to enter human clinical trials and to extend the approach to other viruses by targeting and eliminating their genetic elements. Excision completed a $10M seed financing led by ARTIS Ventures to support these efforts. The company was founded in 2015 out of Temple University’s Lewis Katz School of Medicine in Philadelphia, PA. It is led by founder, president and CEO Thomas Malcolm, Ph.D., and its founding team includes Kamel Khalili, Ph.D., Rob Simmons and David Rowe.

Participated · Series A · Sep 2017

ParkourSC (formerly Cloudleaf) offers a real-time supply chain operations platform powered by hyper-scale graph modeling, AI/ML, and massive real-time data ingestion from IoT and contextual signals. The platform provides continuous visibility into variance from plan, predictive risk mitigation, quality and compliance controls, and aims to eliminate waste and improve resiliency without requiring costly changes to existing infrastructure. ParkourSC has notable traction in temperature-controlled pharmaceutical and life sciences supply chains, claims deployments delivering millions of dollars in ROI, and has established partnerships with cold-chain packaging players such as CSafe Global and Cold Chain Technologies. The company reports continued 300% year-over-year growth in both bookings and ARR for the last two years and has expanded its carrier ecosystem to over 800 carriers and integrations with TMS platforms like MercuryGate and BlueYonder. ParkourSC also maintains an extensible IoT and sensor partner footprint including Qualcomm, Zebra, Sensitech, Tive, Roambee, Wiliot and others. The new funding will support continued revenue growth, leadership hires, engineering expansion in the U.S., India and other regions, and extension of the go-to-market footprint into EMEA. Cloudleaf builds a Supply Chain Digital Visibility Platform that combines IoT, AI/ML and advanced analytics to create a digital twin of the supply chain and process billions of events per second. The platform delivers diagnostic and predictive insights for location, environmental conditions (temperature, humidity, shock), utilization and anomaly detection. Customers reportedly achieve up to 5x improvements in visibility, first-year ROI as high as 70x, and annualized value in the tens of millions of dollars. Cloudleaf serves enterprise customers across pharmaceuticals & life sciences, food & beverage, advanced manufacturing and other industries. The company plans to use new capital to expand its addressable markets, geographic footprint and enterprise customer base. Financially, the company has raised $26 million in the announced Series B, bringing total institutional funding to $39 million. Cloudleaf offers Sensor Fabric™, a mesh of intelligent IoT sensors, endpoints, gateways and cloud technologies that generate a unique digital fingerprint for assets with location and contextual metadata such as temperature, shock and vibration. A patented location engine, middleware and cloud applications transform that metadata into actionable insights, with dashboards for alerts, metrics, trends, analytics and KPIs. The company provides an extensive library of APIs, SDKs and pre-built connectors for integration with ERP, MRP, MES and analytics systems. Initial vertical focus is manufacturing, distribution and pharmaceutical, and Cloudleaf says it is rapidly building solutions applicable to other industry verticals. Key customers named in the article include ArcelorMittal, Dickten Masch Plastics, Magna and Shire. The company announced a $13 million Series A to support commercialization and further product innovation.

Participated · Series B · Apr 2014

Ineda Systems is a Santa Clara, California and Hyderabad, India-based developer of low-power SoCs for the wearables and Internet of Things markets. The company has launched the Dhanush family of Wearable Processor Units (WPU™), a low-power, high-performance SoC that features Hierarchical Computing to run applications at optimized power-performance states and includes an always-on sensor hub for wearable devices. Led by CEO Babu Mandava, Ineda targets the emerging wearable-technology market with its WPU. The company intends to use the new funds to further develop the Dhanush family of Wearable Processor Units. Financially, Ineda raised an additional $2M in Series B from Cisco Investments, bringing the Series B total to $19M. Investors include Cisco Investments alongside Samsung Catalyst Fund, Qualcomm Ventures and Imagination Technologies. Ineda Systems develops ultra-low-power system-on-chip (SoC) semiconductor and software products aimed at the wearables and IoT markets. Its products leverage the company's WPU technology and are designed for smartwatches, health and fitness trackers, and other wearable devices as well as broader IoT applications. The company said it will use new funding to further develop a new class of highly integrated, ultra-low-power semiconductor and software offerings for the wearable segment. Ineda was founded by industry veterans from the United States and India and emphasizes SoC/IP development, architecture and software for next-generation low-power applications. The team and board include CEO Dasaradha Gude and chairman Sanjay Jha, with external board members Lip-Bu Tan and Krishna Yarlagadda. Imagination Technologies is a strategic investor and supplier of IP cores used in Ineda’s products, and the company has offices in Santa Clara, California and Hyderabad, India and has applied for a trademark on its WPU technology.